Interim Financial Information
 12 Months Ended
Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]  
Interim Financial Information
Interim Financial Information (unaudited)
 
QUARTER ENDED
(In thousands, except per share data)
 
March 31,
 
June 30,
 
September 30,
 
December 31,
2016
 
 
 
 
 
 
 
Net sales
$
257,552

 
$
275,037

 
$
268,145

 
$
246,740

Gross profit
67,860

 
73,595

 
73,442

 
68,730

Loss from continuing operations before income taxes
(6,791
)
 
(9,630
)
 
(595
)
 
(12,541
)
Net loss from continuing operations
(8,616
)
 
(11,580
)
 
(5,020
)
 
(17,640
)
Net loss
(8,616
)
 
(11,580
)
 
(5,020
)
 
(17,640
)
Net loss per share from continuing operations—basic
(0.27
)
 
(0.36
)
 
(0.15
)
 
(0.54
)
Net loss per share—basic
(0.27
)
 
(0.36
)
 
(0.15
)
 
(0.54
)
Loss per share from continuing operations—assuming dilution *
(0.27
)
 
(0.36
)
 
(0.15
)
 
(0.54
)
Net loss per share—assuming dilution *
(0.27
)
 
(0.36
)
 
(0.15
)
 
(0.54
)
 
 
 
 
 
 
 
 
 
March 31,
 
June 30,
 
September 30,
 
December 31,
2015
 
 
 
 
 
 
 
Net sales
$
289,024

 
$
286,273

 
$
283,776

 
$
283,265

Gross profit
77,095

 
77,287

 
77,639

 
80,803

Gain (loss) from continuing operations before income taxes
(5,039
)
 
(6,492
)
 
(790
)
 
581

Net loss from continuing operations
(7,514
)
 
(8,217
)
 
(7,790
)
 
(2,929
)
Net earnings from discontinued operations
260

 
—

 
—

 
—

Net loss
(7,254
)
 
(8,217
)
 
(7,790
)
 
(2,929
)
Net loss per share from continuing operations—basic
(0.23
)
 
(0.26
)
 
(0.24
)
 
(0.09
)
Net earnings per share from discontinued operations—basic
0.01

 
—

 
—

 
—

Net loss per share—basic
(0.23
)
 
(0.26
)
 
(0.24
)
 
(0.09
)
Net loss per share from continuing operations—assuming dilution *
(0.23
)
 
(0.26
)
 
(0.24
)
 
(0.09
)
Net earnings per share from discontinued operations—assuming dilution
0.01

 
—

 
—

 
—

Net loss per share—assuming dilution *
(0.23
)
 
(0.26
)
 
(0.24
)
 
(0.09
)


* Net earnings (loss) per share assuming dilution calculated utilizing weighted average shares outstanding - basic in periods in which there is a net loss.

 
The description of significant items affecting continuing operations for each quarter presented are detailed below.

Loss and loss per share for the quarter ended March 31, 2016 reflects recall warranty expense of $1,220,000 ($1,220,000 after tax or $0.04 per share assuming dilution), restructuring charges of $102,000 ($102,000 after tax or $0.00 per share assuming dilution) and net gain on convertible debt derivatives of $604,000 ($604,000 after tax or $0.02 per share assuming dilution).

Loss and loss per share for the quarter ended June 30, 2016 reflects recall warranty expense of $1,670,000 ($1,670,000 after tax or $0.05 per share assuming dilution), restructuring charges of $689,000 ($689,000 after tax or $0.02 per share assuming dilution) and net gain on convertible debt derivatives of $486,000 ($486,000 after tax or $0.02 per share assuming dilution).

Loss and loss per share for the quarter ended September 30, 2016 reflects a gain on the sale of Garden City Medical, Inc. of $7,386,000 ($7,386,000 after tax or $0.23 per share assuming dilution), restructuring charges of $508,000 ($508,000 after tax or $0.02 per share assuming dilution) and net gain on convertible debt derivatives of $1,192,000 ($1,192,000 after tax or $0.04 per share assuming dilution).

Loss and loss per share for the quarter ended December 31, 2016 reflects restructuring charges of $1,148,000 pre-tax ($1,148,000 after tax or $0.04 per share assuming dilution) and net loss on convertible debt derivatives of $1,014,000 ($1,014,000 after tax or $0.03 per share assuming dilution).

Loss and loss per share for the quarter ended March 31, 2015 reflects restructuring charges of $240,000 ($240,000 after tax or $0.01 per share assuming dilution) and increased amortization expense related to the write-off of debt fees related to a debt amendment of $668,000 ($668,000 after tax or $0.02 per share assuming dilution).

Loss and loss per share for the quarter ended June 30, 2015 reflects restructuring charges of $689,000 ($635,000 after tax or $0.02 per share assuming dilution).

Loss and loss per share for the quarter ended September 30, 2015 reflects a tax expense impact as a result of goodwill deducted for tax purposes from the sale of the rentals business of $3,400,000 ($0.11 per share assuming dilution).

Loss and loss per share for the quarter ended December 31, 2015 reflects recall warranty expense reversal of $2,325,000 ($2,325,000 after tax or $0.07 per share assuming dilution) and restructuring charges of $1,031,000 ($957,000 after tax or $0.03 per share assuming dilution).